Multiple viral targets

The designation "Multiple viral targets" is a collective term used in pharmacology to describe the broad-spectrum activity of antiviral agents that interact with various molecular components across different viral species (Nature Microbiology, 2020). Rather than identifying a single protein or receptor, this classification encompasses a range of essential viral enzymes, such as RNA-dependent RNA polymerases and proteases, as well as structural proteins involved in viral entry and assembly (PubChem, 2024). Drugs targeting multiple viral components are particularly valuable in treating emerging viral infections and co-infections where specific narrow-spectrum agents are unavailable (NIH, 2023). However, this broad approach often necessitates careful evaluation of host-cell toxicity, as conserved viral motifs may share similarities with host biological pathways (Journal of Virology, 2021). Consequently, while "Multiple viral targets" represents a strategic focus for pan-antiviral drug development, it does not constitute a single, well-defined biological target in the traditional sense.

Other names

Broad-spectrum viral targetsPan-viral targetsNon-specific viral targets

Inhibition of multiple distinct viral enzymes or structural proteins, such as RNA-dependent RNA polymerase (RdRp) or viral proteases, across diverse viral species (NIH, 2024; Nature Reviews Microbiology, 2021).